You are here
Drugmaker Shire offers to buy Baxalta for US$30b
IRISH drugmaker Shire said on Tuesday that it had offered to buy the biopharmaceutical company Baxalta in an all-stock deal worth about US$30 billion.
Shire said on Tuesday that it had approached Baxalta in early July about a potential combination, but Baxalta concluded,
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org